Zur Seitenansicht


Precision of maximum likelihood estimation in adaptive designs
Verfasser / VerfasserinGraf, Alexandra Christine ; Gutjahr, Georg ; Brannath, Werner
Erschienen in
Statistics in Medicine, Hoboken, 2016, Jg. 35, H. 6, S. 922-941
ErschienenHoboken : Wiley-Blackwell, 2016
DokumenttypAufsatz in einer Zeitschrift
Schlagwörter (EN)maximum likelihood estimation / sample size reassessment / treatment selection / adaptive designs / type-1 error rate / treatment selection / clinical-trials / sample-size / interim / inflation
Projekt-/ReportnummerJ 3344-N26
URNurn:nbn:at:at-ubmuw:3-1835 Persistent Identifier (URN)
 Das Werk ist frei verfügbar
Precision of maximum likelihood estimation in adaptive designs [1.08 mb]
Zusammenfassung (Englisch)

There has been increasing interest in trials that allow for design adaptations like sample size reassessment or treatment selection at an interim analysis. Ignoring the adaptive and multiplicity issues in such designs leads to an inflation of the type 1 error rate, and treatment effect estimates based on the maximum likelihood principle become biased. Whereas the methodological issues concerning hypothesis testing are well understood, it is not clear how to deal with parameter estimation in designs were adaptation rules are not fixed in advanced so that, in practice, the maximum likelihood estimate (MLE) is used. It is therefore important to understand the behavior of the MLE in such designs. The investigation of Bias and mean squared error (MSE) is complicated by the fact that the adaptation rules need not be fully specified in advance and, hence, are usually unknown. To investigate Bias and MSE under such circumstances, we search for the sample size reassessment and selection rules that lead to the maximum Bias or maximum MSE. Generally, this leads to an overestimation of Bias and MSE, which can be reduced by imposing realistic constraints on the rules like, for example, a maximum sample size. We consider designs that start with k treatment groups and a common control and where selection of a single treatment and control is performed at the interim analysis with the possibility to reassess each of the sample sizes. We consider the case of unlimited sample size reassessments as well as several realistically restricted sample size reassessment rules. Copyright (c) 2015 John Wiley & Sons, Ltd.

Das PDF-Dokument wurde 3 mal heruntergeladen.
CC-BY-Lizenz (3.0)Creative Commons Namensnennung 3.0 International Lizenz